Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Combined Modality Therapy × Clear all

NCT04846452 2021-08-12

Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung